Market Cap 37.45B 756M 674M 624M 567M 1.06B 71.65B 1.08B 7.49B 2.94B 2.84B 2.78B 120B P/E 2024
31.9x
P/E 2025 26.8x
Enterprise Value 35.76B 722M 643M 596M 542M 1.02B 68.43B 1.03B 7.15B 2.81B 2.71B 2.65B 114B EV / Sales 2024
3.78x
EV / Sales 2025 5.51x
Free-Float
22.05%
Yield 2024
3.68%
Yield 2025 1.82%
1 day-5.03%
1 week-13.50%
Current month-17.81%
1 month-9.58%
3 months-28.90%
6 months-42.62%
Current year-36.55%
1 week 51.9
Extreme 51.9
60.35
1 month 51.9
Extreme 51.9
68.8
Current year 51.9
Extreme 51.9
132.6
1 year 51.9
Extreme 51.9
132.6
3 years 37.2
Extreme 37.2
132.6
5 years 5.71
Extreme 5.71
132.6
10 years 2.14
Extreme 2.14
132.6
Manager TitleAgeSince
Chief Executive Officer - 2022-08-31
Investor Relations Contact - 2024-06-30
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman - 1981-04-02
Director/Board Member 72 1993-03-30
Director/Board Member 59 2018-04-11
Date Insider Type Main position Quantity % Market Cap. Importance
3/28/22 BuyCompany 101,290 0.0148%
3/21/22 BuyCompany 126,840 0.0185%
3/18/22 BuyCompany 467,287 0.0682%
Change 5-day change 1-year change 3-year change Capi.($)
-5.03%-13.50%-42.90%+4.85% 756M
-0.63%+5.52%+54.26%+111.22% 1,120B
-0.67%-3.95%+30.76%+66.29% 616B
-0.43%+1.01%+22.36%+95.13% 504B
+0.24%+5.58%+35.22%+59.40% 367B
-0.92%-0.60%+67.49%+43.96% 360B
-0.40%+3.53%+19.26%+46.55% 288B
-0.37%+3.11%-1.31%+18.23% 258B
-0.99%+2.40%+40.97%+52.38% 234B
-0.94%+2.70%+25.49%+96.95% 194B
Average -1.04%+1.75%+25.16%+59.50% 394.17B
Weighted average by Cap. -0.59%+3.52%+37.53%+76.16%

Financials

2024 2025
Net sales 8.77B 177M 158M 146M 133M 249M 16.77B 253M 1.75B 689M 664M 650M 28.03B 9.87B 199M 178M 164M 150M 281M 18.89B 285M 1.97B 776M 747M 732M 31.56B
Net income 1.02B 20.66M 18.41M 17.06M 15.51M 29.1M 1.96B 29.58M 205M 80.45M 77.5M 75.88M 3.27B 2.09B 42.15M 37.57M 34.81M 31.65M 59.39M 4B 60.36M 417M 164M 158M 155M 6.68B
Net Debt 513M 10.35M 9.23M 8.55M 7.77M 14.58M 981M 14.82M 103M 40.31M 38.83M 38.02M 1.64B -1.69B -34.03M -30.33M -28.1M -25.55M -47.94M -3.23B -48.73M -337M -133M -128M -125M -5.39B
Projected Income Statement - Annual - EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret
Logo EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS, formerly known as Eczacibasi Ilac Sanayi ve Ticaret A.S., (EIS) is a Turkey-based company active in the pharmaceutical industry through its subsidiaries, affiliates and joint ventures. Its product portfolio consists of drugs for human health, veterinary drugs and personal care products, such as body and facial creams, hair gels, deodorants and various other products. The Company is also engaged in real estate development and construction through its subsidiary, Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., formerly known as Eczacibasi Insaat ve Ticaret A.S. Its subsidiaries also include Eczacibasi Ilac Ticaret A.S. (EIT), EHP Eczacibasi Health Care Products Joint Stock Co. (EHP), and Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., among others. EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a member of Eczacibasi Group of Companies.
Employees
904
Date Price Change Volume
26-10-19 TRY 51.90 -5.03% 4,497,826
26-10-16 TRY 54.65 -2.58% 3,595,370
26-10-15 TRY 56.10 -0.09% 2,259,530
26-10-14 TRY 56.15 -4.34% 4,802,664
26-10-13 TRY 58.70 -2.17% 4,978,429
  1. Stock Market
  2. Stocks
  3. ECILC Stock